Intravenous Acetaminophen in the Emergency Department
Although intravenous acetaminophen has been marketed in over 80 countries since 2001, the product was only recently approved by the Food and Drug Administration, in November 2010. Much debate surrounds who should receive intravenous acetaminophen. A major limitation for use is increased cost compare...
Saved in:
Published in | Journal of emergency nursing Vol. 39; no. 1; pp. 92 - 96 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Mosby, Inc
01.01.2013
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Although intravenous acetaminophen has been marketed in over 80 countries since 2001, the product was only recently approved by the Food and Drug Administration, in November 2010. Much debate surrounds who should receive intravenous acetaminophen. A major limitation for use is increased cost compared with oral or rectal administration. However, potential pharmacokinetic advantages and a reduction in adverse effects compared with nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids have warranted further examination. The emergency department is one patient care area where the availability of an intravenous formulation is beneficial for urgent, short-term administration. Although there is limited American literature to support the use of intravenous acetaminophen, a few European studies in the emergency department raise the consideration for its use. Here, Kwiatkowski and Walker discuss the intravenous acetaminophen in the emergency department. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 ObjectType-Article-2 ObjectType-Feature-1 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0099-1767 1527-2966 |
DOI: | 10.1016/j.jen.2012.08.005 |